Goldman Sachs Investments Mauritius has reportedly offloaded 3.9 lakh shares of Strides Arcolab through the open market route. The shares were sold on an average price of Rs 888.66 valuing the transaction to Rs 35.39 crore. On the other hand, Morgan Stanley Asia (Singapore) PTE has bought 5 lakh shares in the company for an average price of Rs 894.98, through open market route valuing the transaction at Rs 44.74 crore.
Strides Arcolab is a global pharmaceutical company headquartered in Bangalore, India that develops and manufactures wide range of IP-lead niche pharmaceutical products with an emphasis on sterile injectables.
